Skip to content

A Comparative Study of the Effect of Two Partographs on the Cesarean Section Rate in Women in Spontaneous Labour

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02741141
Acronym
PARTODYS
Enrollment
633
Registered
2016-04-18
Start date
2016-09-21
Completion date
2019-10-07
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystocia

Brief summary

In the 2010-french perinatal survey, the overall cesarean section (CS) rate during labour was 21 % and 16% to 38% in case of dystocia. The definition of dystocia is traditionally based on the research led by Friedman in the 1950's on a restricted population sample. Several studies over the last years seem to indicate that the different phases of labour are longer than originally described by Friedman. Our current hypothesis is that the application of a new definition of dystocia would enable a more appropriate management of labour.

Detailed description

The main purpose of this study is to show a significant decrease of the CS rate with the use of the new partograph developed by Neal and Lowe. Secondary purposes are * To reduce the use of oxytocin during labour without increasing maternal or neonatal morbidity; * To decrease immediate per-operative complications and post-operative complications associated with CS

Interventions

OTHERNew partograph based on the studies of Neal and Lowe

The partograph designed by Neal and Lowe includes an action line which if crossed permits an active management of labour. Eventually, the only difference between the two arms is the moment when the active management of labour is started. The oxytocin is administrated according to the department protocol.

OTHERClassical partograph

Classical partograph used as standard care

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age ≥ 18 years * Affiliation to a social security insurance * Written consent given * Singleton pregnancy * Cephalic presentation * ≥37 gestational weeks * Spontaneous onset of labour

Exclusion criteria

* Previous cesarean section * Induction of labour * Intrauterine growth restriction * In utero fetal death * Congenital malformation * Chorioamnionitis * Placenta praevia * Need for an emergency delivery (fetal heart rate abnormalities at admission) * Contra-indication for vaginal delivery * Patient under temporary guardianship, guardianship or judicial protection * Patient included in another study which could interfere with the results of this study

Design outcomes

Primary

MeasureTime frame
Cesarean section rate (all causes)From admission in the labour ward to the delivery (duration from 0 to 24 hours approximately)

Secondary

MeasureTime frameDescription
obstetrical measures associated with possible effects of both strategies on maternal and fetal outcomeFrom the admission in the labour ward until the dismissal from maternity (2 to 5 days)Total amount of oxytocin used (mUI)
Maternal measures associated with possible effects of both strategies on maternal and fetal outcomeFrom the admission in the labour ward until the dismissal from maternity (2 to 5 days)Need for an epidural or general anaesthesia
Neonatal measures associated with possible effects of both strategies on maternal and fetal outcomeFrom the admission in the labour ward until the dismissal from maternity (2 to 5 days)Neonatal arterial umbilical cord pH \< 7,00 and/or BD \> 12 mmol/L

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026